PTC Inc. has recently released its 10-K report, detailing its financial performance for the fiscal year ending September 30, ...

Seaport-based PTC Inc. (Nasdaq: PTC), one of the state's largest public companies by revenue, added 270 workers in the 12 ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $45.00. The company’s shares closed yesterday at ...

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

Startup inspiration can strike anywhere. But for Atlas.co*, a freemium browser-based, real-time mapping tool that's being ...